Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Item
http://www.wikidata.org/entity/Q38388633
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysisCardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4.Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy.Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection.2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Item
http://www.wikidata.org/entity/Q38388633
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of elbasvi ...... I randomized controlled trial.
@en
type
label
Efficacy and safety of elbasvi ...... I randomized controlled trial.
@en
prefLabel
Efficacy and safety of elbasvi ...... I randomized controlled trial.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Efficacy and safety of elbasvi ...... II randomized controlled trial
@en
P2093
P304
P31
P356
10.1016/J.JHEP.2016.07.050
P433
P478
P50
P577
P698
P921